Quantcast
Last updated on April 17, 2014 at 11:49 EDT

Latest antibodies Stories

2013-04-08 20:22:10

TSX Venture: QPT EDMONTON, April 8, 2013 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has recently signed an exclusive license agreement with University of California at Los Angeles to develop and market anti-PSA IgE technology for the treatment of cancer. The technology was developed by Professor Manuel Penichet and Dr. Tracy...

2013-04-08 12:27:53

ROCKVILLE, Md., April 8, 2013 /PRNewswire/ -- OriGene Technologies, Inc., a leading genome wide product company for research and diagnostic applications with operations in the United States and China, announced that it has signed a definitive agreement to acquire all the assets of the Life Science business of SDIX(TM) (NASDAQ: SDIX), a leading provider of biotechnology-based products and services. (Logo: http://photos.prnewswire.com/prnh/20130408/DC90285LOGO) "We anticipate the...

2013-04-08 11:49:56

Potential weakness identified in make-up of these deadly agents can immediately yield a sensitive test By screening a library of a billion llama antibodies on live Ebola viruses in the Texas Biomedical Research Institute's highest biocontainment laboratory, scientists in San Antonio have identified a potential weakness in the make-up of these deadly agents that can immediately yield a sensitive test. "Detecting single viral protein components can be challenging, especially at very low...

Possible HIV Vaccine Found In The Evolution Of Antibodies
2013-04-05 13:09:45

Brett Smith for redOrbit.com - Your Universe Online When HIV enters the human body, it begins an arms race with the immune system which is constantly attempting to develop new ways to destroy the invader. Unfortunately, the body is at some point overwhelmed by a multitude of HIV mutations before the immune system is able to develop a superweapon against the virus. However, some immune systems do develop a superweapon called "broadly neutralizing antibodies” a few years after the...

2013-04-04 16:11:30

Viruses have historically been classified into one of two types — those with an outer lipid-containing envelope and those without an envelope. For the first time, researchers at the University of North Carolina have discovered that hepatitis A virus, a common cause of enterically-transmitted hepatitis, takes on characteristics of both virus types depending on whether it is in a host or in the environment. "The whole universe of virology is divided into two types of viruses —...

2013-04-04 08:28:44

WALTHAM, Mass. and LIANYUNGANG, China, April 4, 2013 /PRNewswire/ -- X-BODY BIOSCIENCES announced today an exclusive alliance with Jiangsu Hengrui Medicine Co., Ltd. ("Hengrui"), in which Hengrui will develop and commercialize a novel antibody program generated from X-BODY's antibody platform for Age-related Macular Degeneration (AMD) in Greater China (including mainland China, Taiwan, Macao, and Hong Kong). Under the terms of the collaboration, Hengrui will fund and lead all preclinical...

2013-04-03 08:27:38

--Automated Multi-Tier ADA Test Combines Screening, Confirmatory and Isotyping Steps in a Single Assay-- SAN DIEGO, April 3, 2013 /PRNewswire/ -- Genalyte, Inc. today announced the launch of its MT-ADA(TM)( )anti-drug antibody (ADA) immunogenicity assay designed to run on the Maverick(TM) Detection System. This test combines screening for the presence of ADAs and the characterization of each detected ADA with a full isotype profile. With minimal required sample preparation and...

2013-03-28 16:24:33

ReportsnReports.com offers 2013 market research reports on polymer biomaterials and protein engineering industry products like monoclonal antibodies, insulin analog and modified EPO. DALLAS, March 28, 2013 /PRNewswire-iReach/ -- Market Research on Biomaterials and Protein Engineering Industry Products with Technology and Applications (Photo: http://photos.prnewswire.com/prnh/20130328/CG85250) The global biomaterials market is poised to grow at a CAGR of 15% from 2012 to 2017 to...

2013-03-25 08:25:56

BREDA, The Netherlands and GHENT, Belgium, March 25, 2013 /PRNewswire/ -- ARGX-112 targets IL22R1, a novel target involved in chronic skin inflammation arGEN-X, a clinical stage biopharmaceutical company specialized in the discovery and development of highly differentiated human monoclonal antibody therapeutics, announces that it has progressed ARGX-112, its fourth therapeutic candidate, into formal preclinical development. ARGX-112 is a novel, fully human antibody...

2013-03-19 12:27:33

NEW YORK, LONDON, BERLIN, PARIS, March 19, 2013 /PRNewswire/ -- The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market [http://www.reportstack.com/product/99233/monoclonal-antibodies-market-in-rheumatoid-arthritis-to-2018-market-characterized-by-large-and-diversified-pipeline-and-low-threat-of-biosimilar-sales-erosion.html ] , constituting four of the global top 20 best-selling drugs. The...